Ignite Creation Date:
2024-07-17 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06468930
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-21
First Post:
2024-03-28
Brief Title:
Efficacy of Adjunctive Low-Level Light Therapy to Intense Pulsed Light for Meibomian Gland Dysfunction
Sponsor:
Chulalongkorn University
Organization:
Chulalongkorn University
Study Overview
Official Title:
Efficacy of Adjunctive Low-Level Light Therapy to Intense Pulsed Light for Meibomian Gland Dysfunction
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to compare the effectiveness of adjunctive low-level light therapy LLLT to intense pulsed light IPL versus intense pulsed light IPL alone for the treatment of meibomian gland dysfunction MGD
The main question it aims to answer is does the adjunctive of low-level light therapy LLLT to intense pulsed light IPL provide more beneficial treatment effects than intense pulsed light IPL alone in treating meibomian gland dysfunction MGD patients
Participants will be randomized into 2 groups adjunctive low-level light therapy LLLT to intense pulsed light IPL group ALLLT IPL and IPL alone group
The main question it aims to answer is does the adjunctive of low-level light therapy LLLT to intense pulsed light IPL provide more beneficial treatment effects than intense pulsed light IPL alone in treating meibomian gland dysfunction MGD patients
Participants will be randomized into 2 groups adjunctive low-level light therapy LLLT to intense pulsed light IPL group ALLLT IPL and IPL alone group
Detailed Description:
In both the IPL group and the ALLLTIPL group the doctor will administer IPL therapy to each participant and apply the Light Modulation special facial mask to their faces The assistant nurse will activate the light power ensuring that the doctor remains blind to treatment allocation Participants in both groups will receive a conventional treatment for MGD including warm compression and lid hygiene Moreover all participants will be advised to use preservative-free artificial tears 4 times daily throughout the study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None